RCM Vendors Push AI for Denials
RCM vendors are increasingly promoting AI as a key tool for financial performance. CureMD is highlighting its AI for predictive analytics to reduce denials, while CareCloud is emphasizing its RCM solutions to boost collections, signaling a competitive focus on automated financial controls.
The push for AI in RCM is a direct response to staggering financial losses, with claim denials costing U.S. hospitals nearly $20 billion annually. Some estimates place the total cost of denial management even higher, at roughly $262 billion per year when considering the broader healthcare system. This financial strain is driving the adoption of AI-powered platforms to protect revenue. Denial rates are on the rise, with some providers seeing initial denials on 15% to 20% of all submitted claims. The administrative burden is significant, as reworking a single denied claim can cost anywhere from $25 to $118. Shockingly, up to 65% of denied claims are never resubmitted, representing a permanent loss of revenue for providers. Vendors are embedding AI and machine learning to move from reactive to predictive denial management. These systems analyze historical data to identify patterns and flag high-risk claims *before* submission. For example, CureMD's platform includes a rules engine with over 20,000 algorithms to enforce compliance and optimize reimbursement accuracy automatically. The competitive landscape now centers on end-to-end automation. CareCloud’s cirrusAI, for instance, generates customized appeal letters by analyzing claim details and specific payer requirements. This level of automation aims to reduce the manual workload on staff, which is critical given widespread staffing shortages and the increasing complexity of payer rules. The U.S. Revenue Cycle Management market was valued at over $172 billion in 2024 and is projected to grow at a compound annual growth rate of 10.1% through 2030. This growth is largely fueled by the demand for AI-driven solutions that can mitigate the financial impact of denials and streamline billing operations. A majority of healthcare organizations, 74%, have either adopted or plan to adopt AI tools within their RCM processes.
